Home
About
Overview
Sharing Data
ORCID
Help
History (23)
Investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment.
Geographic variation in radiologist capacity and widespread implementation of lung cancer CT screening.
Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103.
Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis.
Molecular pathways and therapeutic targets in lung cancer.
See All 23 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Molecular pathways and therapeutic targets in lung cancer.
Molecular pathways and therapeutic targets in lung cancer. Oncotarget. 2014 Mar 30; 5(6):1392-433.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Humans
Molecular Targeted Therapy
Neoplasm Proteins
Neoplasms
Signal Transduction
authors with profiles
Clarissa C. Parker
Ravi Salgia
Thomas Hensing